Werewolf Therapeutics, Inc.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: US95075A1079

USD

0.99

0.01 (0.75%)

Sep 23

NAS

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

SCYNEXIS, Inc.

Aquestive Therapeutics, Inc.

FibroGen, Inc.

CytomX Therapeutics, Inc.

Ocuphire Pharma, Inc.

Capricor Therapeutics, Inc.

Annovis Bio, Inc.

aTyr Pharma, Inc.

Werewolf Therapeutics, Inc.

Anebulo Pharmaceuticals, Inc.

Chimerix, Inc.

Why is Werewolf Therapeutics, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Werewolf Therapeutics, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Werewolf Therapeutics, Inc.

-44.73%

-0.47

146.49%

S&P 500

15.76%

1.20

13.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-5.77%

EBIT to Interest (avg)

-35.10

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.12

Sales to Capital Employed (avg)

0.08

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

58.72%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.53

EV to EBIT

-0.18

EV to EBITDA

-0.18

EV to Capital Employed

-4.80

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-253.55%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company

OPERATING PROFIT(Q)

Highest at USD -8.57 MM

PRE-TAX PROFIT(Q)

Highest at USD -9.9 MM

NET PROFIT(Q)

Highest at USD -9.9 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

-4What is not working for the Company

ROCE(HY)

Lowest at -161.89%

CASH AND EQV(HY)

Lowest at USD 103.5 MM

DEBT-EQUITY RATIO (HY)

Highest at -72.11 %

Here's what is working for Werewolf Therapeutics, Inc.

Operating Profit

Highest at USD -8.57 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Operating Profit trend is quite positive

Operating Profit (USD MM)

Pre-Tax Profit

Highest at USD -9.9 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit

Highest at USD -9.9 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (USD MM)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Werewolf Therapeutics, Inc.

Cash and Eqv

Lowest at USD 103.5 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at -72.11 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Footer loading